Publications

European urology

ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy.

01-03-2016

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.

10-02-2016

Human genetics

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.

01-01-2016

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.

01-11-2015

Cancer immunology, immunotherapy : CII

Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma.

01-10-2015

Science translational medicine

Optimizing sharing of hospital biobank samples.

22-07-2015

BMC medicine

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.

02-07-2015

American journal of human genetics

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.

02-07-2015

Cell host & microbe

Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma.

10-06-2015

Human molecular genetics

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

15-05-2015

Journal of the National Cancer Institute

Prediction of breast cancer risk based on profiling with common genetic variants.

01-05-2015

Journal of the National Cancer Institute

Identification of novel genetic markers of breast cancer survival.

01-05-2015

Breast cancer research : BCR

Common germline polymorphisms associated with breast cancer-specific survival.

22-04-2015

Nature genetics

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.

01-04-2015

Carcinogenesis

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.

01-02-2015

American journal of human genetics

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

08-01-2015

Human molecular genetics

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.

01-01-2015

The journal of pathology. Clinical research

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.

01-01-2015

Human molecular genetics

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.

15-11-2014

Human molecular genetics

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

15-11-2014

PloS one

MicroRNA related polymorphisms and breast cancer risk.

13-11-2014

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

[Not Available].

01-11-2014

Nature communications

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

23-09-2014

Breast cancer research : BCR

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

26-05-2014

The Journal of pathology

Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing.

01-07-2013

Breast cancer research and treatment

Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.

01-11-2011

Human molecular genetics

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

15-08-2011

Nature genetics

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).

01-12-2010

International journal of radiation oncology, biology, physics

Radiation-associated breast tumors display a distinct gene expression profile.

01-02-2010

Breast cancer research : BCR

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.

22-12-2009

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.

10-09-2009

Hereditary cancer in clinical practice

The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype.

17-02-2009

Breast cancer research and treatment

The spectrum of ATM missense variants and their contribution to contralateral breast cancer.

01-01-2008

Cancer research

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.

01-10-2007

Blood

In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma.

15-08-2007

Breast cancer research : BCR

Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.

13-04-2007

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.

01-01-2007

Breast cancer research and treatment

Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers.

01-01-2004

Journal of the National Cancer Institute

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

02-07-2003

Human mutation

IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.

01-05-2003

Nederlands tijdschrift voor geneeskunde

[From gene to disease; ataxia telangiectasia].

01-03-2003

International journal of radiation biology

Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations.

01-05-2000

American journal of human genetics

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

01-02-2000

Human mutation

ATM germline mutations in classical ataxia-telangiectasia patients in the Dutch population.

29-10-1998

The EMBO journal

Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans.

15-11-1996

The EMBO journal

A P-glycoprotein protects Caenorhabditis elegans against natural toxins.

01-05-1995

Proceedings of the National Academy of Sciences of the United States of America

Target-selected gene inactivation in Caenorhabditis elegans by using a frozen transposon insertion mutant bank.

15-08-1993

ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy.

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.

Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma.

Optimizing sharing of hospital biobank samples.

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.

Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma.

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

Prediction of breast cancer risk based on profiling with common genetic variants.

Identification of novel genetic markers of breast cancer survival.

Common germline polymorphisms associated with breast cancer-specific survival.

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

MicroRNA related polymorphisms and breast cancer risk.

[Not Available].

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing.

Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).

Radiation-associated breast tumors display a distinct gene expression profile.

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.

The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype.

The spectrum of ATM missense variants and their contribution to contralateral breast cancer.

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.

In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma.

Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.

Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.

Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers.

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.

[From gene to disease; ataxia telangiectasia].

Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations.

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

ATM germline mutations in classical ataxia-telangiectasia patients in the Dutch population.

Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans.

A P-glycoprotein protects Caenorhabditis elegans against natural toxins.

Target-selected gene inactivation in Caenorhabditis elegans by using a frozen transposon insertion mutant bank.

This site uses cookies